#LXEO Lexeo Therapeutics to Participate in the Chardan Healthcare Conference

#LXEO Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
#LXEO Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
#LXEO Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
🚨 JUST IN: $LXEO
Lexeo to acquire Mantle for up to $21.3M; adds FA pipeline and collaborations